BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 11105614)

  • 1. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants.
    Weber B; Borkhardt A; Stoll-Becker S; Reiss I; Gortner L
    Turk J Pediatr; 2000; 42(3):181-5. PubMed ID: 11105614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia.
    Rova M; Haataja R; Marttila R; Ollikainen V; Tammela O; Hallman M
    Hum Mol Genet; 2004 Jun; 13(11):1095-104. PubMed ID: 15102713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease.
    Lahti M; Marttila R; Hallman M
    Eur J Hum Genet; 2004 Apr; 12(4):312-20. PubMed ID: 14735158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant.
    Hilgendorff A; Heidinger K; Bohnert A; Kleinsteiber A; König IR; Ziegler A; Lindner U; Frey G; Merz C; Lettgen B; Chakraborty T; Gortner L; Bein G
    Acta Paediatr; 2009 Jan; 98(1):112-7. PubMed ID: 18785967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of urokinase gene 3'-UTR polymorphism with bronchopulmonary dysplasia for ventilated preterm infants.
    Lin HC; Su BH; Lin TW; Hsu CM; Wan L; Tsai CH; Tsai FJ
    Acta Paediatr Taiwan; 2004; 45(6):315-9. PubMed ID: 15868845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory distress syndrome: evaluation of genetic susceptibility and protection by transmission disequilibrium test.
    Haataja R; Marttila R; Uimari P; Löfgren J; Rämet M; Hallman M
    Hum Genet; 2001 Sep; 109(3):351-5. PubMed ID: 11702216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants.
    Hilgendorff A; Heidinger K; Pfeiffer A; Bohnert A; König IR; Ziegler A; Merz C; Frey G; Chakraborty T; Gortner L; Bein G
    Genes Immun; 2007 Dec; 8(8):671-7. PubMed ID: 17898783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchopulmonary dysplasia].
    Clément A
    Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
    Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
    West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited disorders of neonatal lung diseases.
    Yurdakök M
    Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplasia: a review.
    Bokodi G; Treszl A; Kovács L; Tulassay T; Vásárhelyi B
    Pediatr Pulmonol; 2007 Oct; 42(10):952-61. PubMed ID: 17726703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
    Yanamandra K; Boggs P; Loggins J; Baier RJ
    Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein polymorphisms and neonatal lung disease.
    Hallman M; Haataja R
    Semin Perinatol; 2006 Dec; 30(6):350-61. PubMed ID: 17142161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic polymorphism of surfactant protein A in neonatal respiratory distress syndrome].
    Zhai L; Wu HM; Wei KL; Zhao SM; Jiang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):295-8. PubMed ID: 18554451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndrome.
    Pulkkinen V; Haataja R; Hannelius U; Helve O; Pitkänen OM; Karikoski R; Rehn M; Marttila R; Lindgren CM; Hästbacka J; Andersson S; Kere J; Hallman M; Laitinen T
    Ann Med; 2006; 38(5):357-66. PubMed ID: 16938805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia.
    Strassberg SS; Cristea IA; Qian D; Parton LA
    Pediatr Pulmonol; 2007 Jan; 42(1):29-36. PubMed ID: 17123322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia.
    Kazzi SN; Quasney MW
    J Pediatr; 2005 Dec; 147(6):818-22. PubMed ID: 16356438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population.
    Rämet M; Haataja R; Marttila R; Floros J; Hallman M
    Am J Hum Genet; 2000 May; 66(5):1569-79. PubMed ID: 10762543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
    Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
    Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.